Publications

Kleinman, M.B., Anvari, M.S., Seitz-Brown, C.J., Bradley, V.D., Tralka, H., Felton, J.W., Belcher, A.M., Greenblatt, A.D., & Magidson, J.F. Psychosocial challenges affecting patient-defined medication for opioid use disorder treatment outcomes in a low-income, underserved population: Application of the social-ecological framework. J Subst Use Addict Treat. 2023 Apr 14;149:209046. doi: 10.1016/j.josat.2023.209046. Epub ahead of print. PMID: 37061189.

Belcher, A. M., Cole, T. O., Massey, E., Billing, A. S., Wagner, M., Wooten, W., Epstein, D. H., Hoag, S. W., Wickwire, E. M., Greenblatt, A. D., Colloca, L., Rotrosen, J., Magder, L., Weintraub, E., Wish, E. D., & Kaptchuk, T. J. (April 12, 2023). Effectiveness of Conditioned Open-label Placebo with Methadone in Treatment of Opioid Use Disorder: A Randomized Clinical Trial. JAMA Network Open, 6(4), e237099. https://doi.org/10.1001/jamanetworkopen.2023.7099

Kozak, Z., Ciccarone, D., Thrul, J., Cole, T. O., Pappas, A. L., Greenblatt, A. D., Welsh, C., Yoon, M., Gann, D., Artigiani, E. E., Wish, E. D., & Belcher, A. M. (February 14, 2023). Harm reduction behaviors are associated with carrying naloxone among patients on methadone treatment. Harm Reduction Journal, 20(1), 17. https://doi.org/10.1186/s12954-023-00745-6

Abidogun, T. M., Cole, T. O., Massey, E., Kleinman, M., Greenblatt, A. D., Seitz-Brown, C. J., Magidson, J. F., & Belcher, A. M. (January 7, 2023). Patient experiences of COVID-19-induced changes to methadone treatment in a large community-based opioid treatment program in Baltimore. Journal of Substance Use and Addiction Treatment. https://doi.org/10.1016/j.josat.2022.208946

Spaderna, M., Kattakuzhy, S., Kang, S.J., George, N., Bijole, P., Ebah, E., Eyasu, R., Ogbumbadiugha, O., Silk, R., Gannon, C., Davis, A., Cover, A., Gayle, B., Narayanan, S., Pao, M., Kottilil, S., Rosenthal, E. (2023). Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use. International Journal of Drug Policy, 111.  10.1016/j.drugpo.2022.103906

Ferré, S., Belcher, A. M., Bonaventura, J., Quiroz, C., Sánchez-Soto, M., Casadó-Anguera, V., Cai, N.-S., Moreno, E., Boateng, C. A., Keck, T. M., Florán, B., Earley, C. J., Ciruela, F., Casadó, V., Rubinstein, M., & Volkow, N. D. (September 30, 2022). Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants. Frontiers in Endocrinology, 13. https://www.frontiersin.org/articles/10.3389/fendo.2022.1014678

Seneviratne, C., Noel, J., Franklin, P. D., & Colloca, L. (September 12, 2022). Editorial: Harnessing placebo mechanisms. Frontiers in Psychiatry, 13. https://doi.org/10.3389/fpsyt.2022.1022762

Cornell, J., Conchas, A., Wang, X., Fink, J. C., Chen, H., Kane, M. A., Pilli, N., Ait‐Daoud, N., Gorelick, D. A., Li, M. D., Johnson, B. A., & Seneviratne, C. (September 11, 2022). Validation of serotonin transporter as a quantitative biomarker of heavy drinking and its comparison to ethyl glucuronide/ethyl sulfate: A randomized, double‐blind, crossover trial. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/acer.14931

Seneviratne, C., Gorelick, D. A., Lynch, K. G., Brown, C., Romer, D., Pond, T., Kampman, K., & Kranzler, H. R. (September 2, 2022). A randomized, double‐blind, placebo‐controlled, pharmacogenetic study of ondansetron for treating alcohol use disorder. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/acer.14932

Israel, B., Wiprovnick, A. E., Belcher, A. M., Kleinman, M. B., Ramprashad, A., Spaderna, M., & Weintraub, E. (September 1, 2022). Practical Considerations for Treating Comorbid Posttraumatic Stress Disorder in the Addictions Clinic. Psychiatric Clinics of North America, 45(3), 375–414. https://doi.org/10.1016/j.psc.2022.05.003

Ramprashad, A., Burnett, G. M., & Welsh, C. (September 2022). Harm Reduction. Psychiatric Clinics of North America, 45(3), 529–546. https://doi.org/10.1016/j.psc.2022.04.005

Cornell, J., Taj, A., Sivinski, J., Yin, M., Bhatia, P., Oula, D., Fatschel, S., Franklin, P., Noel, J., Colloca, L., & Seneviratne, C. (August 18, 2022). Integration of virtual platforms for enhanced conference experience: Data-based evidence from the Society of Interdisciplinary Placebo Studies 2021 conference. Frontiers in Communication, 7. https://doi.org/10.3389/fcomm.2022.857661

Clifton, J. M., Belcher, A. M., Greenblatt, A. D., Welsh, C. M., Cole, T. O., & Davis, A. K. (August 5, 2022). Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder. Journal of Psychedelic Studies. https://doi.org/10.1556/2054.2022.00214

Magidson, J. F., Kleinman, M. B., Bradley, V., Anvari, M. S., Abidogun, T. M., Belcher, A. M., Greenblatt, A. D., Dean, D., Hines, A., Seitz-Brown, C. J., Wagner, M., Bennett, M., & Felton, J. W. (August 3, 2022). Peer recovery specialist-delivered, behavioral activation intervention to improve retention in methadone treatment: Results from an open-label, Type 1 hybrid effectiveness-implementation pilot trial. International Journal of Drug Policy, 108. https://doi.org/10.1016/j.drugpo.2022.103813

Orme, S., Zarkin, G. A., Dunlap, L. J., Nordeck, C. D., Schwartz, R. P., Mitchell, S. G., Welsh, C., O’Grady, K. E., & Gryczynski, J. (August 1, 2022). Cost and Cost Savings of Navigation Services to Avoid Rehospitalization for a Comorbid Substance Use Disorder Population. Medical Care, 60(8), 631–635. https://doi.org/10.1097/MLR.0000000000001743

Anvari, M. S., Kleinman, M. B., Massey, E. C., Bradley, V. D., Felton, J. W., Belcher, A. M., & Magidson, J. F. (July 2022). “In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention. Journal of Substance Abuse Treatment. https://doi.org/10.1016/j.jsat.2022.108721

Mannes, Z. L., Hasin, D. S., Martins, S. S., Gonçalves, P. D., Livne, O., de Oliveira, L. G., de Andrade, A. G., McReynolds, L. S., McDuff, D., Hainline, B., & Castaldelli-Maia, J. M. (June 2022). Do varsity college athletes have a greater likelihood of risky alcohol and cannabis use than non-athletes? Results from a National Survey in Brazil. Brazilian Journal of Psychiatry, 44(3), 289–297. https://doi.org/10.1590/1516-4446-2021-2236

Huffman, M., Cloeren, M., Ware, O. D., Frey, J. J., Greenblatt, A. D., Mosby, A., Oliver, M., Imboden, R., Bazell, A., Clement, J., & Diaz-Abad, M. (May 2022). Poor Sleep Quality and Other Risk Factors for Unemployment Among Patients on Opioid Agonist Treatment. Substance Abuse: Research and Treatment, 16. https://doi.org/10.1177/11782218221098418

Welsh, C., Doyon, S., & Hart, K. (April 2022). Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations. International Journal of Drug Policy, 102, 103591. https://doi.org/10.1016/j.drugpo.2022.103591

Brokus, C., Kattakuzhy, S., Gayle, B., Narayanan, S., Davis, A., Cover, A., Eyasu, R., Ebah, E., Ogbumbadiugha-Weekes, O., Hoffmann, J., Silk, R., Stevens, J., Mount, J., Gannon, C., Nussdorf, L., Mathur, P., Bijole, P., Jones, M., Kier, R., … Rosenthal, E. (March 1, 2022). Suboptimal Uptake, Retention, and Adherence of Daily Oral Prexposure Prophylaxis Among People With Opioid Use Disorder Receiving Hepatitis C Virus Treatment. Open Forum Infectious Diseases, 9(3). https://doi.org/10.1093/ofid/ofab658

Nordeck, C. D., Welsh, C., Schwartz, R. P., Mitchell, S. G., O’Grady, K. E., & Gryczynski, J. (March 2022). Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug and Alcohol Dependence Reports, 2. https://doi.org/10.1016/j.dadr.2022.100031

Mitchell, S. G., Nordeck, C. D., Lertch, E., Ross, T. E., Welsh, C., Schwartz, R. P., & Gryczynski, J. (February 18, 2022). Patients with substance use disorders receiving continued care in skilled nursing facilities following hospitalization. Substance Abuse, 43(1), 848–854. https://doi.org/10.1080/08897077.2021.2007512

Ware, O. D., Frey, J. J., Cloeren, M., Mosby, A., Imboden, R., Bazell, A. T., Huffman, M., Hochheimer, M., Greenblatt, A. D., & Sherman, S. A. (December 2021). Examining Employment and Employment Barriers Among a Sample of Patients in Medication-Assisted Treatment in the United States. Addictive Disorders & Their Treatment, 20(4), 578–586. https://doi.org/10.1097/ADT.0000000000000295

Purcell, R., Bindra, A., Blauwet, C., Budgett, R., Currie, A., McDuff, D., Mountjoy, M., Putukian, M., & Gouttebarge, V. (November 18, 2021). A sporting chance. The Lancet Psychiatry, 8(12), 1033–1034. https://doi.org/10.1016/S2215-0366(21)00397-7

Bettencourt, A. F., Allen, C., Coble, K., Hibbert, T., & Sarver, D. E. (November 29, 2021). Trends in Mental Health Concerns Reported to Two Pediatric Mental Health Care Access Programs During the COVID-19 Pandemic. Psychiatric Services. https://doi.org/10.1176/appi.ps.202100479

Blevins, D., Seneviratne, C., Wang, X.-Q., Johnson, B. A., & Ait-Daoud, N. (November 1, 2021). A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis. Drug and Alcohol Dependence, 228. https://doi.org/10.1016/j.drugalcdep.2021.109074

Charest, J., Grandner, M. A., Athey, A. B., McDuff, D., & Turner, R. W. (November 1, 2021). Substance Use Among Collegiate Athletes Versus Non-athletes. Athletic Training & Sports Health Care, 13(6), e443–e452. https://doi.org/10.3928/19425864-20210720-01

Belcher, A. M., Coble, K., Cole, T. O., Welsh, C. J., Whitney, A., & Weintraub, E. (October 28, 2021). Buprenorphine Induction in a Rural Maryland Detention Center During COVID-19: Implementation and Preliminary Outcomes of a Novel Telemedicine Treatment Program for Incarcerated Individuals with Opioid Use Disorder. Frontiers in Psychiatry, 12. https://www.frontiersin.org/article/10.3389/fpsyt.2021.703685

Clark, A. E., Goodwin, S. R., Marks, R. M., Belcher, A. M., Heinlein, E., Bennett, M. E., & Roche, D. J. O. (October 2, 2021). A Narrative Literature Review of the Epidemiology, Etiology, and Treatment of Co-Occurring Panic Disorder and Opioid Use Disorder. Journal of Dual Diagnosis, 17(4), 313–332. https://doi.org/10.1080/15504263.2021.1965407

Sweeney, S., Coble, K., Connors, E., Rebbert-Franklin, K., Welsh, C., & Weintraub, E. (October 2, 2021). Program development and implementation outcomes of a statewide addiction consultation service: Maryland Addiction Consultation Service (MACS). Substance Abuse, 42(4), 595–602. https://doi.org/10.1080/08897077.2020.1803179

Stull, T., Morse, E., & McDuff, D. R. (September 2021). Substance Use and Its Impact on Athlete Health and Performance. Psychiatric Clinics of North America, 44(3), 405–417. https://doi.org/10.1016/j.psc.2021.04.006

Weintraub, E., Seneviratne, C., Anane, J., Coble, K., Magidson, J., Kattakuzhy, S., Greenblatt, A., Welsh, C., Pappas, A., Ross, T. L., & Belcher, A. M. (August 27, 2021). Mobile Telemedicine for Buprenorphine Treatment in Rural Populations with Opioid Use Disorder. JAMA Network Open, 4(8), e2118487. https://doi.org/10.1001/jamanetworkopen.2021.18487

Maldarelli, M. E., Traver, E. C., Norcross, G., Gann, D., Kattakuzhy, S., Welsh, C., & Schmalzle, S. A. (August 5, 2021). Acute Limb Ischemia Caused by Inadvertent Arterial Drug Self-Injection: A Case Report. American Journal of Case Reports, 22. https://doi.org/10.12659/AJCR.932903

Currie, A., Blauwet, C., Bindra, A., Budgett, R., Campriani, N., Hainline, B., McDuff, D., Mountjoy, M., Purcell, R., Putukian, M., Reardon, C. L., & Gouttebarge, V. (August 3, 2021). Athlete mental health: future directions. British Journal of Sports Medicine, 55(22), 1243–1244. https://doi.org/10.1136/bjsports-2021-104443